Statin Treatment and Duration Associated with Reduced Risk of Hemorrhagic Stroke
December 09, 2022

Similar reduction in risk was reported for both lobar and nonlobar intracranial hemorrhage with longer statin treatment associated with greater protection, according to Danish investigators.

Bempedoic Acid Meets Primary Endpoint in Key Cardiovascular Outcomes Trial: CLEAR
December 08, 2022

Approved in 2020 as Nexletol, bempedoic acid as the first ATP citrate lyase inhibitor and oral non-statin therapy to meet the MACE-4 primary endpoint.

Morning Exercise Reduces Risk for Cardiovascular Disease in a New Study of UK Adults
December 05, 2022

Being most physically active in the late morning had a 16% decreased risk of coronary artery disease and a 17% decreased risk of stroke compared to midday.

Cardiac Rehab and Primary Care, with PM&R Specialist Jonathan Whiteson, MD
November 30, 2022

"Cardiac rehabilitation is for life," says the NYU Langone Rusk Rehabilitation medical director of cardiac/pulmonary rehab, and he advocates empathy and compassionate understanding.

Increased Risk of Stroke, CV Event after Herpes Zoster Persists Beyond 12 Years
November 29, 2022

Study participants who had HZ were at 30% greater sustained risk of stroke and CHD vs those who had not had HZ in this large multicohort prospective study.

Daily Dose: Alcohol Use & Stroke in Young Adults
November 08, 2022

Your daily dose of clinical news you may have missed.

Moderate-to-heavy Alcohol Consumption in Young Adulthood May Lead to Early Stroke, Warn New Study Findings
November 07, 2022

Study authors saw a positive dose-response relationship driven by hemorrhagic stroke in young adults who were moderate-to-heavy drinkers in their 20s and 30s.

Apixaban May be the Safer DOAC in Afib, Suggests First Large Comparative Analysis
November 04, 2022

Apixaban was associated with up to a 28% lower risk of GI bleeding vs the 3 other direct oral anticoagulants in the first large-scale comparative analysis.

Black Patients with Afib Significantly Less Likely to Receive Oral Anticoagulation at Hospital Discharge
October 31, 2022

Black patients were also at significantly increased risk of stroke, bleeding, and mortality vs White patients 1 year following discharge.

Apixaban Found More Effective than Rivaroxaban in Patients with AFib and Valvular Heart Disease
October 19, 2022

In the absence of randomized controlled head-to-head trials comparing the 2 anticoagulants, study authors say clinicians should consider their findings when choosing treatment.